What are the treatment options for patients with low testosterone levels, specifically regarding testosterone replacement therapy (TRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Low Testosterone Levels

Testosterone replacement therapy (TRT) is recommended for men with consistently low testosterone levels (<300 ng/dL on at least two early morning measurements) who exhibit symptoms of hypogonadism to improve quality of life and reduce morbidity. 1

Diagnosis Criteria

  • Definition of low testosterone: Total testosterone levels <300 ng/dL measured on at least two separate early morning occasions 1
  • Symptoms requiring evaluation:
    • Reduced energy and endurance
    • Diminished work/physical performance
    • Fatigue
    • Depression and reduced motivation
    • Poor concentration and impaired memory
    • Irritability
    • Reduced sex drive
    • Changes in erectile function
    • Infertility 1

Treatment Options

1. Testosterone Formulations

  • Topical gels (1.62%):

    • Starting dose: 40.5 mg applied once daily to shoulders and upper arms
    • Adjustable between 20.25-81 mg based on serum levels
    • Advantages: Easy application, stable serum levels, fewer mood fluctuations 2
    • Target serum level: 450-600 ng/dL (middle tertile of normal range) 1
  • Oral testosterone undecanoate:

    • Initial dose: 200 mg orally twice daily
    • Can be titrated to 100-400 mg based on response 3
    • Newer option with convenient oral administration
  • Injectable testosterone:

    • More cost-effective option ($156.24 annual cost vs $2135.32 for transdermal) 4
    • May cause more fluctuations in testosterone levels 1

2. Lifestyle Modifications

  • Weight management
  • Regular exercise
  • Mediterranean diet (emphasizing fruits, vegetables, beans, whole grains, nuts, fish)
  • Moderate alcohol consumption (<21 units/week) 4, 1

Monitoring Protocol

  • Initial monitoring (3-6 months):

    • Testosterone levels (target: 450-600 ng/dL)
    • Hematocrit (discontinue if >54%)
    • PSA
    • Symptom response 1
  • Long-term monitoring (annually):

    • Testosterone levels
    • Hematocrit
    • PSA (in men ≥40 years)
    • Symptom evaluation 1

Benefits of TRT

  • Improved sexual function
  • Enhanced sense of well-being
  • Increased lean body mass
  • Decreased body fat
  • Increased bone density 1
  • Potential improvement in insulin sensitivity and glycemic control in men with metabolic syndrome 4

Risks and Contraindications

Contraindications:

  • Breast or prostate cancer
  • Hematocrit >50%
  • Severe untreated sleep apnea
  • Severe lower urinary tract symptoms
  • Uncontrolled heart failure
  • Current or future fertility desires (with traditional TRT) 1

Potential adverse effects:

  • Increased hematocrit (polycythemia)
  • Potential cardiovascular risks (FDA warning about possible increased risk of heart attack and stroke) 1, 2
  • Worsening of benign prostatic hyperplasia symptoms
  • Edema
  • Gynecomastia
  • Suppression of spermatogenesis 3

Special Considerations

  • Men desiring fertility: Consider alternative treatments such as clomiphene citrate or exogenous gonadotropins rather than traditional TRT 5
  • Recent cardiovascular events: Delay TRT for 3-6 months 1
  • Secondary exposure risk: Strict adherence to application instructions for topical formulations to prevent transfer to women and children 2

Treatment Algorithm

  1. Confirm diagnosis: Two morning testosterone measurements <300 ng/dL + symptoms
  2. Rule out contraindications
  3. Select appropriate formulation based on:
    • Patient preference
    • Cost considerations (injectable more affordable)
    • Fertility concerns (avoid traditional TRT if fertility desired)
  4. Initiate treatment at recommended starting dose
  5. Monitor response at 3-6 months and adjust dose as needed
  6. Continue long-term monitoring annually

TRT should be considered a long-term therapy, as discontinuation typically results in return to hypogonadal state within 6 months 6.

References

Guideline

Testosterone Replacement Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.